RGS20 reduces glioma stemness and temozolomide resistance by intrinsically inhibiting the WNT/β-catenin signaling pathway.
Saved in:
| Title: | RGS20 reduces glioma stemness and temozolomide resistance by intrinsically inhibiting the WNT/β-catenin signaling pathway. |
|---|---|
| Authors: | Xie, Yang1,2 (AUTHOR), Li, Qi1,2,3 (AUTHOR), Ma, Yecheng1,2 (AUTHOR), Yang, Yongchang1,2 (AUTHOR), Jin, Xingyu1,2 (AUTHOR), Yi, Tailong1 (AUTHOR), Ge, Xianglian1 (AUTHOR), Xu, Xing1 (AUTHOR), Yang, Xuejun4 (AUTHOR), Huang, Qiang5 (AUTHOR), Lu, Yalin6 (AUTHOR), Li, Peng6 (AUTHOR), Li, Wenliang6 (AUTHOR), Wang, Xiaoguang6 (AUTHOR), Piao, Yingzhe6 (AUTHOR) 13602132633@163.com, Jin, Xun1 (AUTHOR) jinx2354@163.com |
| Source: | Scientific Reports. 11/28/2025, Vol. 15 Issue 1, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
